BioHarvest (BHST) Q1 2026 Earnings Transcript

Image source: The Motley Fool.

DATE

Thursday, May 14, 2026 astatine 8 a.m. ET

CALL PARTICIPANTS

• Chief Executive Officer — Zaki Rakib

• Chief Operating Officer — Bar Dichter

• Co-Founder, Board Director — Ilan Sobel

Need a punctuation from a Motley Fool analyst? Email [email protected]

Full Conference Call Transcript

Zaki Rakib: Thank you, Dory, and convey you each for joining america this morning. BioHarvest Sciences is an concern works compartment civilization biotech institution and a person successful Botanical Synthesis, which is simply a patented non-GMO level exertion that industrializes what quality different does dilatory and produces high-value plant-derived compounds and botanical compositions without increasing the works itself. Using proprietary works compartment biology, elicitation technologies, AI-driven improvement and concern standard bioreactors, BioHarvest creates highly consistent, bioavailable and patent-protected precision botanics oregon compounds possessing enhanced potency and purity compared to the archetypal plant, on with the characteristics for commercialized scalability.

The level has already demonstrated important commercialized validation done VINIA, BioHarvest's flagship Blood Flow wellness product, portion besides serving arsenic the instauration of the company's rapidly expanding CDMO concern crossed pharmaceutical, nutraceutical, nutrition, cosmetic and fragrance markets. With much than $100 cardinal invested successful its level technology, 15 patents, multidisciplinary technological capabilities arsenic demonstrated successful assorted objective publications and proven concern standard manufacturing, BioHarvest has 2 businesses representing its dual maturation engines: The D2C concern that has already generated cumulative VINIA-based income of adjacent to $100 million; and the CDMO concern that is good positioned arsenic a strategical spouse for next-generation plant-based innovation crossed the nutraceutical, pharmaceutical, cosmeceutical and nutrition industries.

These 2 businesses person antithetic operating models that person compelled the operating changes we person precocious communicated. The two-lens model for managing the institution is designed to optimize performance, superior allocation and maturation execution. As such, and arsenic announced past quarter, we volition beryllium reporting revenues and operations with this two-lens approach. With this, Bar volition supply a much elaborate summary of our numbers for this quarter. Bar?

Bar Dichter: Thank you, Zaki, and bully morning, everyone. I volition supply you with a elemental reappraisal of our fiscal results. A afloat breakdown is disposable successful our SEC filings and successful the property merchandise that crossed the ligament earlier marketplace opened today. Please enactment that each figures are successful U.S. dollars unless stated otherwise. Revenues for the archetypal 4th of 2026 accrued 8% year-over-year to $8.5 cardinal from $7.9 cardinal successful the aforesaid twelvemonth agone quarter. Cost of gross was $3.5 cardinal compared to $3.3 cardinal for the aforesaid play past year.